New England Journal of Medicine news from FierceHealthcare
News
Study: Drugs may do as well as an angioplasty
In many cases, people with chronic chest pain who aren't at great risk for a heart attack may do much better with drug treatment than an angioplasty, according to a new study. Angioplasty is still Read more...
Study: Clot-sucking device cuts death rates for heart attacks
A new study suggests that a vacuum-cleaner-like device that sucks block clots out of the arteries of heart attack victims before angioplasty can have a dramatic effect on survival rates. In fact, the Read more...
Study: Social networks can have impact on health behavior
Underscoring the results of existing studies, new research has found that social networks can have a much bigger impact on health behaviors than previously suspected. The study, published in the New Read more...
Hospital night shifts severely lacking
The differences between being treated at a hospital at night and during the day often can be daunting, the Wall Street Journal's health blog points out. Not only is the quality care not as high Read more...
SPOTLIGHT: Critics challenge direct-to-consumer TV ads for stent
Over the last several months, consumers have been viewing a 60-second television ad for Johnson & Johnson's Cypher stent which, of course, plays up its potential benefits. Now, two critics of Read more...
ALSO NOTED: Revenue growth slows for PA hospitals, but they remain profitable; JAMA rips journal use for off-label pharma marke
> Revenue growth has slowed for Pennsylvania hospitals, but still continues, and they continue to enjoy relatively healthy margins. Read more...
FDA says Glaxo didn't report Avandia data
According to a new letter from the agency, GlaxoSmithKline didn't turn over post-marketing data about Avandia to the FDA, a lack of disclosure that looks pretty unfortunate given subsequent reports Read more...
SPOTLIGHT: NEJM issues correction over tobacco ties to cancer study
Editors at the venerable New England Journal of Medicine must be a bit embarrassed this week, having had to issue a correction admitting that it should have disclosed that a lung-cancer detection Read more...
SPOTLIGHT: Study: Last-minute drug approvals less safe
When FDA reviewers cram, do they perform poorly on the test? A new study concludes that yes, when drugs are approved right on deadline, they're more likely to cause safety problems later. The Read more...
Study: Older blood raises heart surgery risk
Right now, it's commonplace for patients getting heart surgery to get blood that has been waiting in a refrigerator for two weeks or longer. As it turns out, this may be raising their risk of Read more...
Get more New England Journal of Medicine coverage at:
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies